chenodeoxycholic acid has been researched along with Autoimmune Diseases in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, D; Alpini, G; Banales, JM; Beuers, U; Björnsson, E; Bowlus, C; Carbone, M; Chazouillères, O; Dalekos, G; De Gottardi, A; Gershwin, ME; Harada, K; Hirschfield, G; Invernizzi, P; Jones, D; Krawitt, E; Lanzavecchia, A; Lian, ZX; Ma, X; Manns, M; Mavilio, D; Mieli-Vergani, G; Quigley, EM; Sallusto, F; Shimoda, S; Strazzabosco, M; Swain, M; Tanaka, A; Terziroli Beretta-Piccoli, B; Trauner, M; Tsuneyama, K; Vergani, D; Vierling, JM; Zigmond, E | 1 |
| de Veer, RC; Laschtowitz, A; Schramm, C; Van der Meer, AJ | 1 |
| Gershwin, ME; Hirschfield, GM; Lleo, A; Wang, GQ | 1 |
| Anaya, JM; Gershwin, ME; Lleo, A; Marzorati, S | 1 |
| Lindor, KD; Momah, N | 1 |
| Bowlus, CL; Gershwin, ME; Invernizzi, P; Lleo, A; Mousa, HS | 1 |
| Ali, AH; Lindor, KD | 1 |
| Li, B; Ma, X; Wang, QX | 1 |
8 review(s) available for chenodeoxycholic acid and Autoimmune Diseases
| Article | Year |
|---|---|
The challenges of primary biliary cholangitis: What is new and what needs to be done.
Topics: Antibodies, Antinuclear; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Congresses as Topic; Female; Humans; Liver; Liver Cirrhosis, Biliary; Ursodeoxycholic Acid | 2019 |
Diagnosis and treatment of primary biliary cholangitis.
Topics: Autoantigens; Autoimmune Diseases; Bezafibrate; Biomarkers; Biopsy; Chenodeoxycholic Acid; Cholagogues and Choleretics; Disease Progression; Drug Therapy, Combination; Elasticity Imaging Techniques; End Stage Liver Disease; Fatigue; Female; Humans; Immunoglobulin M; Liver; Liver Cirrhosis, Biliary; Liver Function Tests; Liver Transplantation; Middle Aged; Off-Label Use; Prognosis; Pruritus; Quality of Life; Severity of Illness Index; Sjogren's Syndrome; Survival Rate; Treatment Outcome; Ursodeoxycholic Acid | 2020 |
Primary biliary cholangitis.
Topics: Autoimmune Diseases; Biomarkers; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fatigue; Humans; Pruritus; Risk Factors; Ursodeoxycholic Acid | 2020 |
Primary biliary cholangitis: a comprehensive overview.
Topics: Anti-Inflammatory Agents; Autoimmune Diseases; Biopsy; Budesonide; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Fibric Acids; Humans; Immunosuppressive Agents; Liver; Prognosis; Ursodeoxycholic Acid | 2017 |
Primary biliary cirrhosis in adults.
Topics: Adult; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Humans; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Ursodeoxycholic Acid | 2014 |
Advances in pharmacotherapy for primary biliary cirrhosis.
Topics: Autoimmune Diseases; Bile Acids and Salts; Budesonide; Chenodeoxycholic Acid; End Stage Liver Disease; Female; Fibric Acids; Humans; Liver; Liver Cirrhosis, Biliary; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Treatment Failure; Ursodeoxycholic Acid | 2015 |
Obeticholic acid for the treatment of primary biliary cholangitis.
Topics: Animals; Autoimmune Diseases; Chenodeoxycholic Acid; Cholagogues and Choleretics; Cholangitis; Cholestasis; End Stage Liver Disease; Genome-Wide Association Study; Humans; Liver Cirrhosis, Biliary; Randomized Controlled Trials as Topic; Ursodeoxycholic Acid | 2016 |
[Research advances in autoimmune liver diseases in 2016].
Topics: Autoimmune Diseases; Biomedical Research; Chenodeoxycholic Acid; Cholangitis; Cholangitis, Sclerosing; Clinical Trials, Phase III as Topic; Hepatitis, Autoimmune; Humans; Liver Cirrhosis, Biliary; Liver Diseases | 2017 |